Summary
Several regulatory provisions have been introduced during the last decade that might interfere with the conduct of experimental medical science. In order to study their impact on the source of information within one major field, heart research, a total of 3579 abstracts from the 1978 and 1988 Scientific Sessions of the American Heart Association were analysed with respect to their source of information. There was no change in overall fractions of classical patient studies (45070) or experimental animal studies (30%) for the 2 years although regulations have been introduced in both areas. There was no evidence that the volume of circulatory physiology, a subset that extensively utilizes animal experimentation, declined relative to other subsets of the composite information base. The fraction of cell culture studies clearly rose over the period at the expense of in vitro laboratory studies but not as replacement for animal experimentation.
Particularly tight regulations on experiments with selected species apparently explains why dogs and cats are less frequently used relative to rats, rabbits, ferrets and pigs which represent the alternatives. Nevertheless, the absolute number of dog studies doubled over the 10-year period and this species still remains the most widely used experimental model in heart research. The study does not reveal directly what is actually performed within the research community but rather identifies the source of information for those studies that are considered to bring about pertinent new information in modern heart research. Received 8 May 1990; accepted 19 September 1990 Keywords: Cardiovascular research methods; Historic trends; Impact of regulatory measures; Laboratory animals; Medical science legislation Knowledge of human disease stems from a variety of sources. Apart from studies on patients, animal experimentation has since long served as an important information source. In recent years, however, a series of regulatory provisions have been introduced in most countries that might interfere with the conduct of scientific investigation. What can and cannot be done to patients, laboratory animals, and genetic material has been specified through legislation, institutional regulations or recommendations. Concurrently, costs have escalated, and new methods and scientific concepts have lead to other ways of conducting scientific work. Of particular interest here are methods which can be regarded as alternatives to potentially hazardous or ethically dubious practices.
What impact have these developments had on the source of scientific information? The consistent structure of the annual Scientific Sessions of the American Heart Association (AHA) offers an opportunity to approach this question within the field of heart research. Contributions to the 1978 and 1988 programmes were therefore analysed in order to detect differences over the lO-year period.
Materials and methods
All abstracts from the 51st and 61st Scientific Sessions were studied and placed into one of the 11 categories listed in Table 1 . A total of 3579 abstracts were analysed; 1002 from 1978 and 2577 from 1988. The 1978abstract book contains Each abstract was given one code. Studies including patients as well as healthy controls were classified into PAT category.
Studies involvingseveralspeciesare categorized, once, according to this hierarchy. Includes dietary regimens on animals. 991 numbered abstracts; one was withdrawn from the programme and 12 were given a special letter code (AHA, 1978) . The corresponding 1988 book contains 2607 numbered abstracts; 6 entries were nonexistent and 24 were withdrawn (AHA, 1988) . In order to study developments in the use of laboratory animals the main animal category was subdivided according to species used (Table 2) .
Identical coding was performed for the 2 years, and each abstract was assigned one code.
Composite studies which comprised patients as well as healthy human subjects were categorized to the former code; studies including patients as well as research animals were categorized to the former; studies comprising several species were categorized hierarchically ( Table 2) . Statistical analysis of differences in 1978/1988 fractions was performed by x 2 goodness of fit (Zar, 1984) . The term fraction in this text refers to the portion of a category relative to all abstracts for the corresponding year; similarly for specified subsets of a category.
Results
The majority of 1988 contributions were classical patient studies (45' 3 1170)or experimental animal studies (29' 71170); neither fraction was different from 1978 ( Fig. I) . Of the remaining contributions, 2 categories revealed different fractions: the portion of laboratory studies had fallen from 12·81170 to 8, 51170, whereas studies on isolated cells had increased from 1·71170 to 6'41170. These 2 alterations roughly balanced and might therefore indicate transfer of laboratory studies to cultured cell systems over the lO-year period.
A break-down analysis of animal studies is presented in Fig. 2 and shows several developments within this category. Most striking are clear reductions in the fractions of dogs and cats for experimental purposes. Since the overall fraction of animal studies was not changed (29'5070 in 1978; 29,7% in 1988) , studies that previously used dogs or cats appear to have been transferred to other species on a relative scale. Most of this effect was absorbed by rat studies, but also more frequent use of rabbits, pigs and ferrets helps explain the transition. same conclusions as for the entire programme concerning animal profile. Subprogrammes that makeup the Scientific Sessions traditionally carry different category profiles and it is therefore possible that altered category profiles could be reflected in this study. The 1988 programme contained significantly less communications within the Thrombosis, Cardiovascular Surgery, Arteriosclerosis, and Cardiopulmonary subprogrammes (Table 3) . This reduction was broadly compensated across most remaining subprogrammes, induding the new Nutrition subprogram me of 1988. However, a break -down analysis showed that none of the alterations in subprogram me composition were substantial enough to fully explain the category alterations reported in Fig. 1 . Less fractions of laboratory studies occurred within Basic Science/Circulation, High Blood Pressure Research, and Thrombosis. Cell culture systems 
Discussion
This study was performed within the field of heart research which has such a substantial scientific activity that it can be regarded as reasonably representative for medical science at large. Within the consistent framework of the became predominant in Basic Science/Circulation, Arteriosclerosis, Thrombosis, and Featured Research.
Similarly, changed species profile within the animal category could not be explained by alterations in subprogrammes. Thus, the category changes illustrated in Figs 1 and 2 represent the development among contributors to the AHA Scientific Sessions rather than slightly different subprogramme composition over the 10-year period. 1978 1988 annual AHA Scientific Sessions there is a good opportunity to detect whether the sources of information have changed over time. This forum is widely recognized as one of the most important marketplaces for introduction and exchange of new knowledge. The programme therefore represents the best available collection of what can be considered as relevant new information. This analysis revealed that classical patient studies and experimental animal studies constituted 45070 and 30% of the programmes, respectively; both fractions remained stable over the 1978-1988 period. Considering recent developments in regulatory provisions to the effect of restricted human as well as animal experimentation, this was not reflected in the 1988 programme. Although a closer examination could not be performed, the impression is that more prospective than retrospective patient studies have appeared on the grounds of stronger scientific value. It was also the impression that the fraction of invasive patient studies was not increased, notably because of the introduction of several noninvasive image techniques over the period. Firm conclusions on this can, however, not be drawn on the basis of this study.
Production of scientific knowledge is a sort of chain process. Tightened restrictions on patient studies thus transfer problem solving to animal models. Tightened restrictions in this area, in turn, press for other sources of information. In analysing such transfers, therefore, it becomes necessary to consider all elements in the composite production of knowledge.
Within categories other than patient and animal studies there was a clear development towards studies on isolated cells at the expense of traditional laboratory studies. Cell culture systems are commonly considered as an alternative to experimental animal studies. However, such transfers could not be identified and this notion was thus not substantiated. A more likely explanation is that refined technology of cell culture has opened new lines of research previously performed in vitro as laboratory studies. Because circulatory physiology is widely represented in both studies on cells and laboratory studies as 
Basic research;
Basic science! circulation Thrombosis defined here, there is no evidence that the impact of circulatory physiology within heart research has declined. Also, studies of human physiology in healthy individuals that constitute approximately 30/0 did not change significantly.
It should be noted that fractions in this material are relative to the total amount of studies for each year, which was 2·6 times higher in 1988. Thus, although the fraction of, for example, dog studies was significantly reduced, the actual number of such studies increased from 149 in 1978 to 309 in 1988. Similar reasoning applies to all categories and reflects a much higher general scientific activity in 1988 than in 1978.
Circulatory physiology extensively utilizes experimental animal models. Although legislation and other regulations that aim at reducing animal experimentation have been introduced, this had no significant impact on the fraction of animal studies as such and certainly not on its total volume. Neither cell culture nor model experiments replaced animal experiments to a noticeable extent. Regulatory measures in this field are particularly restrictive on popular pet animals like dogs and cats, and this is, therefore, the most likely explanation for reduced fractions of these two species. Although the dog still remains clearly the most dominating laboratory animal in heart research, the use of rats, pigs, or rabbits appears to have replaced the use of dogs to some extent. These latter species, together with ferrets which actually were not reported on the 1978 programme at all, also have replaced most of the use of cats.
It is acknowledged that factors other than regulatory measures might contribute to the transitions. Rising costs and housing capacity for dogs and cats are such factors. Application of clinical studies for what had earlier been explored in dogs and cats is possible but such a transition is unlikely because modern legislation aims at the opposite for the sake of patient safety.
The reasons for apparently modest effect of tightened regulatory provisions for the purpose of replacing animal experimentation with socalled alternative methods have recently been Lekven thoughtfully discussed by Zbinden (1990) . He points out that investigators turn to in vitro systems like cell culture because they find it appropriate for solving the problem at hand, and not because they explicitly wish to save animals. Such reasons for transition is not much publicized and therefore largely unknown to legislators and concerned citizens. Zbinden also brings to attention that the authorities find themselves torn between several moves and interests. On the one hand they are pressed by organizations and individuals that are seriously concerned about human rights versus animal rights. On the other hand there is increasing pressure for extensive animal testing of effects and side effects of therapeutic and diagnostic methods for use in patients. Similarly, escalating litigation against drug manufacturers and the medical profession for compensation fOllowing side effects or mishap press the institutions to a much broader evaluation of products and practices before they are released for general use.
Limitations
The annual variation in the intervening years was not correspondingly analysed. Emerging trends over the decade should therefore be stated with due care. It is, however, reasonable to assume that any marked developments should show by analysing the 1988communications vs 1978since major alterations in programme structure and the selection process have not taken place. This study is not directly representative for investigations that actually are performed within the research community; there are several reservations that must be considered.
First, a similar analysis of submitted but rejected abstracts to the Scientific Sessions programmes is unavailable. Although the overall acceptance rate was 33% for both years (Austen, 1978; Healy, 1988) , it is possible that the acceptance rate might vary significantly between subprogrammes.
Second, studies may have been performed without the intention of presentation at these annual meetings. But since there is a strong drive within the research community for having works recognized and discussed in major forums like this one, it is a reasonable assumption that the majority of studies that did bring about relevant information are included.
Third, the entire programme was more internationalized over the decade (Austen, 1978; Healy, 1988) , whereas concomitant developments in legislation, etc., were not necessarily parallel world wide. These circumstances might therefore blur interpretation of this study to some extent. However, it is fair to say that although the legislative developments in different countries have proceeded at different paces, they move in the same direction because minimizing human and animal experimentation as much as possible forms the common drive for new laws and regulations across the world.
Fourth, it is possible that changes in the priorities of funding agencies had taken place during the period. Such changes, however, might well have been prompted by the very same regulations that are discussed in this paper.
Fifth, one should not generalize too widely from the trends appearing within heart research to other fields of medical science. In the only other study comparable to the present analysis, Zbinden found different profiles that characterized subsets of 6649 communications at the 1989 FASEB meeting (1990) . Heart research was, however, not categorized close enough to what is done in the present material to allow for direct comparison. But his analysis of 2070 communications within General Physiology carries a profile well compatible with a Cardiovascular Physiology subset in my study.
Finally, the conclusions made in this paper presume that selection of submitted abstracts for the programme is capable of identifying those abstracts that bring new and well-substantiated information to the scientific marketplace. In this regard one must rely on the Association's wellestablished practices, consistent programme structure and selection process.
